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Dear Editor,
We are writing in reference to a previously reported case of lateonset, rapidly progressive, MRI-negative myelitis after COVID-19
illness [1] to report our patient’s remarkable recovery. A 60-year-old
woman with obesity (BMI 45.6) and borderline diabetes had presented
with late-onset partial myelitis that progressed to complete myelitis over
3 months, which manifested 9 weeks after she had COVID-19. As a
result, the patient developed paraplegia, became wheelchair-bound, and
developed weakness in her hands. Extensive infectious, inflammatory
autoimmune, neoplastic, and paraneoplastic investigations were nega
tive, while serum SARS-CoV-2 IgM and repeat IgG tests were reactive.
Initial brain and spinal magnetic resonance imaging (MRI) had been
normal, but later MRIs revealed bilateral corticospinal tracts affecting
the posterior limbs of internal capsules extending to the cerebral pe
duncles and pons, as well as multifocal T2 signal changes in the cervical
cord (C2-C6) on sagittal STIR without associated enhancement. She had
been treated with intravenous methylprednisolone (1 g for 5 days),
which led to no improvement. Afterward, she received 5 rounds of
plasma exchange (PLEX), which did result in mild improvement. The
patient had also reported further improvement after discharge from
rehabilitation, where she was able to stand with bilateral assistance and
move her legs against antigravity. Also, we apologize for having initially
reported the wrong age (65 years) for this patient; she was 60 years old
at the time of the presentation.
The patient subsequently received prednisone 20 mg daily for over a
month followed by a slow taper over 3 months, and she recovered
considerably 8 months after hospitalization. She regained significant
strength in her lower extremity, ambulated with a walker, and
continued to receive outpatient physical and occupational therapy.
Follow-up brain and cervical spine MRI with and without contrast 8
months after her last MRI showed significant improvement of the T2/
FLAIR signal abnormality that had been seen involving the corticospinal
tracts within the corona radiata extending to the posterior limb of the
internal capsules bilaterally, without restricted diffusion or enhance
ment (Fig. 1 A). She has also shown progressive normalization of the
high signal intensity that was previously seen within the cervical cord.

No new areas of cord signal abnormalities have been identified (Fig. 1
B). Repeat aquaporin-4 IgG and myelin oligodendrocyte glycoprotein
IgG antibodies tested with cell-based assays were also negative.
Our patient made a remarkable recovery despite having accumulated
significant disability from myelitis. Unfortunately, there had been an
initial delay in the treatment. Interestingly, the previously seen
abnormal signal changes on MRI of brain and spine also improved over
time. However, we thought that the bilateral corticospinal tract findings
could have been a feature of Wallerian degeneration, perhaps an intense
axonal degeneration without demyelination due to viral-induced path
ogenesis. The patient is delighted with the care and treatment that she
received, and she has consented to publication of her progress to help
the medical community understand the pathogenic disease mechanisms
involved in her case. (Note that the patient was made aware of the initial
error regarding her age.).
The SARS-CoV genome has been detected in the cytoplasm of neu
rons in the brain; thus, it is likely that SARS-CoV-2, given its similar
invasion mechanism, can lead to neuronal dysfunction either directly or
indirectly through immune-mediated mechanisms [2]. Related to but
distinct from meningoencephalitis are the possible para-infectious or
post-infectious complications of the nervous system due to SARS-CoV-2
infection, such as acute disseminated encephalomyelitis, transverse
myelitis, and Guillain-Barré syndrome. These are generally considered
to result from an adaptive immune response against endogenous or "self"
molecules; i.e., molecular mimicry. However, these sequelae are
consistently found in older individuals (> 50 years old), particularly
those with underlying vascular, metabolic, pulmonary, and obesity
comorbidities. The exaggerated immune response may stem from a
dysregulated or impaired regulatory immune function responsible for
suppressing the immune response after it has been mounted [3]. Older
individuals are more likely to have dysregulated immune function due to
immunosenescence [4], and individuals with metabolic diseases, hy
pertension, and obesity also have a deficiency in immune regulatory
mechanisms [5,6]. Nonetheless, we speculate that immunotherapy may
play a role in helping individuals such as our patient, who had continued
to decline until she received high-dose pulse steroids and PLEX.
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Fig. 1. A): Significant improvement of the T2/FLAIR signal abnormality that had been seen involving the corticospinal tracts within the corona radiata extending to
the posterior limb of the internal capsules bilaterally, without restricted diffusion or enhancement. (B): Progressive normalization of the high signal intensity that was
previously seen within the cervical cord. No new areas of cord signal abnormalities have been identified.
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